Clinical Trial Detail

Clinical Trials

Clinical Trial Detail

Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

Complete title: Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia

Research Study Number 8508
 
Principal Investigator Lauri Burroughs, MD
 
Phase Pilot

Research Study Description

The purpose of this study is to determine the feasibility of comparing outcomes of patients treated de novo with immunosuppressive therapy (IST) versus matched unrelated donor (MUD) hematopoietic stem cell transplant (HSCT) for pediatric acquired severe aplastic anemia.

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "Look up trial at NIH" link above. **

Other eligibility criteria may apply.

Research Study Number 8508
 
Contact Seattle Cancer Care Alliance Intake Office
 
Telephone 800-804-8824 / 206-606-1024
 

Keywords: Anemia, Aplastic; Hematologic Malignancies; Pediatric Cancers, Miscellaneous; Anemia; Bone Marrow Diseases

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials